Charles River Laboratories International, Inc. (CRL) has a consensus analyst rating of Buy, based on 36 analysts covering the stock. Of those, 25 recommend buying, 11 recommend holding, and 0 recommend selling.
The analyst consensus price target for CRL is $202.17, representing a +12.7% upside from the current price of $179.31. Price targets range from a low of $175.00 to a high of $260.00.
